Current
42.0×
5-Year Average
62.5×
All-Time High
107.7×
All-Time Low
11.1×
P/FCF Ratio daily chart for IDEXX Laboratories (IDXX)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
Historical P/FCF Ratio for IDEXX Laboratories (IDXX) from 2001 to 2025
| 2025 | $54.19B | $1.05B | 51.4× | +9.0× | |
| 2024 | $33.84B | $798.08M | 42.4× | -17.3× | |
| 2023 | $46.12B | $772.88M | 59.7× | -26.2× | |
| 2022 | $33.83B | $394.15M | 85.8× | -2.0× | |
| 2021 | $55.86B | $636.00M | 87.8× | +8.8× | |
| 2020 | $42.73B | $540.44M | 79.1× | +5.3× | |
| 2019 | $22.42B | $303.93M | 73.8× | +15.8× | |
| 2018 | $16.07B | $277.15M | 58.0× | +11.9× | |
| 2017 | $13.67B | $296.57M | 46.1× | +7.3× | |
| 2016 | $10.47B | $269.78M | 38.8× | -10.8× | |
| 2015 | $6.62B | $133.44M | 49.6× | +9.2× | |
| 2014 | $7.08B | $175.15M | 40.4× | +7.4× | |
| 2013 | $5.53B | $167.36M | 33.0× | +2.0× | |
| 2012 | $5.08B | $163.89M | 31.0× | +5.6× | |
| 2011 | $4.25B | $167.24M | 25.4× | -3.1× | |
| 2010 | $3.98B | $139.53M | 28.5× | +1.7× | |
| 2009 | $3.10B | $115.88M | 26.8× | -21.0× | |
| 2008 | $2.13B | $44.69M | 47.8× | -3.2× | |
| 2007 | $3.57B | $69.99M | 51.0× | -13.2× | |
| 2006 | $2.47B | $38.47M | 64.2× | +39.4× | |
| 2005 | $2.29B | $92.35M | 24.8× | -3.5× | |
| 2004 | $1.80B | $63.67M | 28.3× | +12.2× | |
| 2003 | $1.61B | $100.26M | 16.0× | +3.6× | |
| 2002 | $1.10B | $88.17M | 12.5× | -20.9× | |
| 2001 | $966.00M | $28.98M | 33.3× | — |
- 202551.4×
- 202442.4×
- 202359.7×
- 202285.8×
- 202187.8×
- 202079.1×
- 201973.8×
- 201858.0×
- 201746.1×
- 201638.8×
- 201549.6×
- 201440.4×
- 201333.0×
- 201231.0×
- 201125.4×
- 201028.5×
- 200926.8×
- 200847.8×
- 200751.0×
- 200664.2×
- 200524.8×
- 200428.3×
- 200316.0×
- 200212.5×
- 200133.3×
About P/FCF Ratio at IDEXX Laboratories (IDXX)
IDEXX Laboratories (IDXX) P/FCF ratio is 42.0× as of June 5, 2026. The 5-year average is 62.5×. The sector median currently stands at 19.8×. The current ratio is at the 2th percentile of its own 10-year history.
IDEXX Laboratories (IDXX) historical P/FCF ratio has ranged from a low of 11.1× (2002) to a high of 107.7× (2023) in the available daily series.
The price-to-free-cash-flow (P/FCF) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) free cash flow. It is calculated as market cap ÷ TTM free cash flow, where free cash flow = operating cash flow − capital expenditures. Because FCF cannot be inflated by non-cash accounting items, P/FCF is often considered a cleaner measure of "earnings-power valuation" than P/E — especially for capital-intensive businesses where depreciation diverges from real cash outflows.
IDEXX Laboratories P/FCF Ratio by Year
IDEXX Laboratories P/FCF Ratio 2025: 51.4×
IDEXX Laboratories (IDXX) P/FCF ratio in 2025 was 51.4×, expanded from 42.4× the prior year.
IDEXX Laboratories P/FCF Ratio 2024: 42.4×
IDEXX Laboratories (IDXX) P/FCF ratio in 2024 was 42.4×, contracted from 59.7× the prior year.
IDEXX Laboratories P/FCF Ratio 2023: 59.7×
IDEXX Laboratories (IDXX) P/FCF ratio in 2023 was 59.7×, contracted from 85.8× the prior year.
IDEXX Laboratories P/FCF Ratio 2022: 85.8×
IDEXX Laboratories (IDXX) P/FCF ratio in 2022 was 85.8×, contracted from 87.8× the prior year.
IDEXX Laboratories P/FCF Ratio 2021: 87.8×
IDEXX Laboratories (IDXX) P/FCF ratio in 2021 was 87.8×.
Sector peers by P/FCF Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/FCF Ratio — table
Healthcare peers of IDEXX Laboratories (IDXX), ranked by P/FCF ratio.
| 17.8× | |
| 17.8× | |
| 16.9× | |
| 16.9× | |
| 16.7× | |
| 16.4× | |
| 16.3× | |
| 15.9× | |
| 14.0× | |
| 13.5× | |
| 12.9× | |
| 12.5× | |
| 12.4× | |
| 12.2× | |
| 12.1× | |
| 11.3× | |
| 10.7× | |
| 10.4× | |
| 10.3× | |
| 10.0× | |
| 9.6× | |
| 9.1× | |
| 9.1× | |
| 6.9× | |
| 2.5× |
- 17.8×
- 16.9×
- 16.7×
- 16.4×
- 13.5×
- 12.9×
- 12.4×
- 10.7×
- 10.3×
- 9.1×
- 9.1×
- 6.9×
- 2.5×
Frequently asked questions
IDEXX Laboratories (IDXX) Key Financials
Charts, filings, and peer comparison for every metric